Glaukos (GKOS) Cash from Operations (QoQ) (2014 - 2026)
Glaukos (GKOS) Cash from Operations (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn |
| 10 | Glaukos | 8.66 Bn | 8.56 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -283.34% |
| Dec 31, 2025 | 167.71% |
| Sep 30, 2025 | -244.58% |
| Jun 30, 2025 | 137.68% |
| Mar 31, 2025 | -3,753.06% |
| Dec 31, 2024 | 105.29% |
| Sep 30, 2024 | 47.81% |
| Jun 30, 2024 | 45.77% |
| Mar 31, 2024 | -217.58% |
| Dec 31, 2023 | -30.57% |
| Sep 30, 2023 | -0.09% |
| Jun 30, 2023 | 73.47% |
| Mar 31, 2023 | -643.81% |
| Dec 31, 2022 | 84.40% |
| Sep 30, 2022 | -117.23% |
| Jun 30, 2022 | -224.88% |
| Mar 31, 2022 | 310.15% |
| Dec 31, 2021 | -126.14% |
| Sep 30, 2021 | 140.70% |
| Jun 30, 2021 | 76.90% |